Arcus Biosciences, Inc. (RCUS) Q4 Earnings and Revenues Surpass Estimates

Arcus Biosciences, Inc. (RCUS) delivered earnings and revenue surprises of 428.32% and 3,898.41%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for…

Pactiv Evergreen Inc. (PTVE) Q4 Earnings and Revenues Surpass Estimates

Pactiv Evergreen Inc. (PTVE) delivered earnings and revenue surprises of 64.44% and 3.65%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for…